Aldeyra extends operational cash runway into 2029

• Aldeyra updated financial guidance to extend its operational cash runway into 2029.
• Update reflects reported cash and cash equivalents of $45.1 million as of June 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aldeyra Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609290700BIZWIRE_USPR_____20260929_BW404066) on September 29, 2026, and is solely responsible for the information contained therein.